Paola Maroni

Dr. Paola Maroni

IRCCS, Istituto Ortopedico Galeazzi, Milan, Italy
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2010 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
PBPaola Bendinelli
Paola Bendinelli
EMEmanuela Matteucci
Emanuela Matteucci
GDGiada Dogliotti
Giada Dogliotti
Massimiliano Marco Corsi RomanelliMassimiliano Marco Corsi Romanelli
Massimiliano Marco Corsi Romanelli
Giuseppe BanfiGiuseppe Banfi
Giuseppe Banfi
MDMaria Alfonsina Desiderio
Maria Alfonsina Desiderio

1 October 1999 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
RRRoberta Ricciarelli
Roberta Ricciarelli
Paola MaroniPaola Maroni
Paola Maroni
NÖNesrin Özer
Nesrin Özer
JZJean-Marc Zingg
Jean-Marc Zingg
AAAngelo Azzi
Angelo Azzi

8 July 2006 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
Paola MaroniPaola Maroni
Paola Maroni
PBPaola Bendinelli
Paola Bendinelli
EMEmanuela Matteucci
Emanuela Matteucci
MDMaria Alfonsina Desiderio
Maria Alfonsina Desiderio
CXCR4 is a chemokine receptor probably involved in the homing of metastatic breast cancer, and its expression is modulated by tumor environmental stimuli such as hepatocyte growth factor (HGF) and hypoxia. Here, we demonstrate that, depending on the stimulus, different transcription factors can cooperate in enhancing CXCR4 transcription in MCF-7 breast cancer cell line. In HGF-treated MCF-7 cells, the DNA binding of Ets1 activated by MAPK1/ERK1/2 transduction pathway as well as the DNA binding of NF-κB played a critical role in CXCR4 transcription and protein induction. Under HGF stimulation, the blockade of these transcription factors by dominant negatives and inhibitors prevented the expression of CXCR4 receptor, the activity of a gene reporter driven by CXCR4 promoter sequence and the chemoinvasion toward the CXCL12 ligand. NF-κB was activated also by hypoxia and contributed, with HIF-1, to the increase in CXCR4 expression. The results suggest that Ets1, specifically activated by HGF, might cooperate with NF-κB activity to enhance the invasive/metastatic phenotype of breast carcinoma cells.

1 June 2010 in European Journal of Cancer
Verified
Journal Article
Closed access
SPSara Previdi
Sara Previdi
Paola MaroniPaola Maroni
Paola Maroni
EMEmanuela Matteucci
Emanuela Matteucci
Massimo BrogginiMassimo Broggini
Massimo Broggini
PBPaola Bendinelli
Paola Bendinelli
MDMaria Alfonsina Desiderio
Maria Alfonsina Desiderio

1 January 2012 in Biotechnology Advances
Verified
Journal Article
Closed access
Giovanni VitaleGiovanni Vitale
Giovanni Vitale
SZSilvia Zappavigna
Silvia Zappavigna
MMMonica Marra
Monica Marra
ADAlessandra Dicitore
Alessandra Dicitore
Stefania MeschiniStefania Meschini
Stefania Meschini
Michele CaragliaMichele Caraglia
Michele Caraglia

1 July 2013 in European Journal of Cancer
Verified
Journal Article
Closed access
PBPaola Bendinelli
Paola Bendinelli
Paola MaroniPaola Maroni
Paola Maroni
EMEmanuela Matteucci
Emanuela Matteucci
ALAlessandro Luzzati
Alessandro Luzzati
GPGiuseppe Perrucchini
Giuseppe Perrucchini
MDMaria Alfonsina Desiderio
Maria Alfonsina Desiderio